Turn college debt into an investment – Green Bay Press Gazette

Steve Van Remortel, For USA TODAY NETWORK-Wisconsin Published 2:02 p.m. CT June 1, 2017 | Updated 4 hours ago

Steve Van Remortel(Photo: Courtesy of Steve Van Remortel)

There is a lot of conversation and debate about college students who have an enormous amount of debt when they are finished with school.

A lot of those conversations are centered on the rising costs of a two- or four-year college education and the higher interest rates being charged on the future leaders of our country.These are legitimate concerns that need to be resolved.But I would suggest there is a larger problem with student debt, and it comes with a viable solution.

In a recent research study by Deloittes Center for the Edge, they determined that only 12.7 percentof the workforce is passionate about their work. Think about that for a minute.If more than 87 percent of the workforce is not passionate about what they do for a living, you could infer that most students are entering the workforce lacking passion about their career choice as well.In simple terms, students are taking on debt without a career plan they are passionate about.

The solution and process to develop a passionate career plan has four simple steps. The first step is to take a behavioral science assessment to understand your natural behavioral style.The next step is to define the top three passions in your life. The third step is to define career options that wrap your natural behavioral style around a passion in your life. The final step is to choose one of the career options that provide you the greatest opportunity for success.

This process can be completed at any age, but the best case scenario is early in high school. While high school students learn other important sciences like biology and chemistry, very few students understand behavioral science or their natural behavioral style, which is developed by the time you are 7 years old.

SM Advisors/Stop The Vanilla has partnered with the Howard-Suamico School District to change this through the Academic and Career Planning Initiative.The pilot program provides a behavioral style assessment and career counseling to juniors and seniors in high school to help them wrap their natural style around a passion in their life.It allows students to talk about who they are, and what they like to do.You can see the passion and enthusiasm pick up in every student in the class as they start getting clarity on their future.Several students came up to me after our class to talk about their specific careers like a pediatric nurse or a teacher.

It helps students set a course for their lives before they even set foot in a college or technical school.Prior to high school graduation every single student should have a career plan that wraps their natural style around a passion in their life. When you are passionate about what you do and you deliver it naturally, you excel at it and get rewarded for it.

We are planning to expand this program because it will lead to more passionate careers that will turn college debt into an investment.For example, I recently interviewed a young man who graduated with $88,000 in student loans and he paid it off in three years. The simple reason: he is passionate about and loves what he does for a living, excels at it and is getting rewarded for it.College debt turns into an investment when it leads to a passionate career.Its about living a passion, not just having a job.

Steve Van Remortel is a professional speaker, strategist, adviser and author of Stop Selling Vanilla Ice Cream. Contact him at steve@stopsellingvanillaicecream.com or go to http://www.smadvisors.com or http://www.stopsellingvanillaicecream.com. His column runs monthly.

Read or Share this story: http://gbpg.net/2sj6bm0

The rest is here:
Turn college debt into an investment - Green Bay Press Gazette

Quinn on Nutrition: Nutritional myths and half-truths – Journal Times

One of my treasured books is a gigantic volume of words and pictures that defines distinct elements in the English language.

Yes, I know I can Google the same information. But I find it satisfying to thumb through the pages of my American Heritage Dictionary for in-depth meanings to words. So, in my book, the thought that books are out of date is a myth.

A myth, according to my dictionary, refers to a popular belief, a fiction or half-truth. And boy, do we have them in the field of nutrition. Here are a few highlighted in Environmental Nutrition, a newsletter authored by registered dietitian nutritionists:

Gluten-free foods are healthier. Unless you have celiac disease or another medical reason to avoid gluten a protein that occurs naturally in wheat, rye and barley there is no additional nutrition benefit from eating gluten-free foods.

Whole wheat or wheat in general is bad for you. Again, if you are sensitive to gluten (a protein in wheat that gives structure to baked bread) or have a true allergy to wheat, any type of wheat product is not good for you. For the rest of us, whole wheat and other whole grain products have been found to lower internal inflammation, which can decrease our risk for cancer, diabetes, rheumatoid arthritis and heart disease.

We dont need to limit salt if we dont have high blood pressure. Its true that some people are more salt-sensitive than others. But even if salt does not raise your blood pressure, it can damage the lining of blood vessels and increase the stiffness of blood-carrying arteries, commonly known as hardening of the arteries. Too much salt can also weaken the heart muscle and do damage to kidneys, according to scientists at the University of Delaware. Our goal? Less than 2,300 milligrams a day is recommended for most healthy people.

Farm-raised fish is not healthy. According to experts with the Monterey Bay Aquarium Seafood Watch program (www.seafoodwatch.org), many popular types of seafood such as salmon and shrimp can be safely farm-raised in addition to being caught in the wild. Because of improved methods of aquaculture (fish farming), most talapia and catfish are now farm-raised; so are oysters and many clams and mussels. Safe farming methods may even help improve the quality of our water, says Seafood Watch.

Soy can cause cancer and feminize men. These charges simply are not true, say researchers. Human studies show that soy foods do not increase cancer risk and in some cases, may lower it. For example, consuming soy foods during childhood and adolescence may help lower ones risk for breast cancer. What about women recovering from a type of breast cancer known to be estrogen receptor positive? They can safely enjoy moderate amounts of soy foods one or two daily servings of soy beverage, edamame, tofu or soy nuts according to the latest research reported by the American Institute of Cancer Research.

Barbara Quinn, who writes this column for the Monterey County Herald, is a registered dietitian and certified diabetes educator affiliated with Community Hospital of the Monterey Peninsula. She is the author of Quinn-Essential Nutrition (Westbow Press, 2015). Email her at to barbara@quinnessentialnutrition.com.

Read more from the original source:
Quinn on Nutrition: Nutritional myths and half-truths - Journal Times

Bacterial pathogenesis Campylobacter follows the clues – Nature.com


Nature.com
Bacterial pathogenesis Campylobacter follows the clues
Nature.com
Campylobacter jejuni is a commensal bacterium that colonizes the intestinal tracts of avian species and other animals, but it is also an enteric pathogen in humans that causes diarrhoeal disease. C. jejuni can distinguish between different intestinal ...

and more »

See the original post:
Bacterial pathogenesis Campylobacter follows the clues - Nature.com

‘C. diff. Science’ Honors Microbiology Professionals Dedicated to … – Florida Newswire

TAMPA, Fla. /Florida Newswire/ The C Diff Foundation hosts C. diff. Science on Sept. 14 to honor professionals dedicated to the scientific research and development in the Clostridium difficile (C. difficile, C. diff.) community worldwide, chaired by Professor Simon M. Cutting, PhD, of Molecular Microbiology at Royal Holloway, University of London.

The free live webinar will take place from 8 a.m. 12 p.m. ET, Sept. 14, 2017.

Professor Cutting, Event Chair and guest presenter, shares the platform with seven fellow scientists focused on their contributions involving the most common pathogen identified, and leading healthcare-associated infection (HAI) Clostridium difficile.

C. difficile infections can be acquired and diagnosed in infants and across the life-span with a higher risk involving our senior citizens and that is why it is imperative to learn about a C. difficile infection, its most common symptoms, the treatments available, and environmental safety products to prevent the spread of this spore-bacteria and to help reduce C. difficile infection recurrences.

On September 14th fellow professionals in the C. diff. community, and those who share a common interest, will have the opportunity to gain knowledge from scientists around the globe who have dedicated their professional lives researching and developing new concepts, new theories, and the progress towards a better understanding pursuing future developments in Clostridium difficile (a.k.a., C. difficile, C.diff.) infection prevention, treatments, and environmental safety products worldwide, states Nancy C Caralla, Executive Director.

About the C Diff Foundation:

The C Diff Foundation, a 501(c)(3) non-profit, founded in 2012 by Nancy C Caralla, a nurse diagnosed and treated for Clostridium difficile (C. diff.) infections.

Through her own journeys and witnessing the passing of her father diagnosed with sepsis secondary to C. difficile infection involvement, Nancy recognized the need for greater awareness through education, the research being conducted by the government, industry, and academia and better advocacy on behalf of patients, healthcare professionals, and researchers worldwide working to address the public health threat posed by this devastating infection.

For webinar information contact event coordinators: info@cdiffscience.org and visit the event website: http://cdiffscience.org/ to register for this free webinar.

For C Diff Foundation information please visit: https://cdifffoundation.org/.

Read the original here:
'C. diff. Science' Honors Microbiology Professionals Dedicated to ... - Florida Newswire

FSU researchers receive $2.8 million grant to search for the origin of personality traits impacting longevity – Florida State News

Angelina Sutin, assistant professor in the department of behavioral sciences and social medicine, has received a $2.8 million grant from the National Institutes of Health.

Our personality predicts more than just the type of friends we may have. It also provides significant clues about our health and can even predict how long we might live.

Yet little is known about how our personality forms relative to what we know about its consequences on health across the lifespan.

Florida State University College of Medicine Assistant Professor Angelina Sutin is seeking answers with the help of a $2.8 million National Institutes of Health grant.

As part of a five-year study, her team will work to identify prenatal and childhood neighborhood risk factors contributing to the development of personality traits most consequential for healthy aging. A better understanding of these relationships is the first step toward earlier interventions for improving health outcomes.

A number of biological, social and behavioral influences affect pregnancy. Did the mother smoke, drink, use drugs, suffer from depression or experience physical or mental abuse?

In childhood, similar influences vary from child to child depending on where they lived and the relative socioeconomic factors in play.

The broader goal is to understand where personality comes from in childhood to have a better sense of how we could intervene, Sutin said. One thing we are looking at, for example, is what factors might be involved in helping some kids to be more resilient than others.

Sutin plans to integrate three established frameworks of health research addressing those factors into one theoretical model examining the influences on formation of personality and the eventual health consequences. She will be assisted by FSU College of Medicine faculty researchers from the departments of behavioral sciences and social medicine, biomedical sciences and geriatrics.

The research centers on three longtime behavioral and biological health studies conducted in the United States, United Kingdom and Australia. The studies, involving thousands of participants assessed over a span of several decades, look at risk factors ranging from prenatal health to childhood place of residence.

The U.S. study will allow Sutin to look more closely at relative neighborhood safety, family income and education and potential links with health outcomes.

Even though the participants in these studies are from three completely different cultural contexts, if you grow up in vulnerable circumstances, regardless of where it is, its still vulnerable circumstances, Sutin said. Were going to be able to look at that in early childhood with the Australian and the English data, young adulthood in the English data and middle adulthood into old age with the U.S. data.

Leslie Beitsch, chair of the department of behavioral sciences and social medicine, said Sutin is renowned for her exceptional research.

Dr. Sutins work is often cited in the lay press but is even more influential within health psychology academic circles, and its easy to understand why, Beitsch said. Projects like this offer the potential to unlock new therapeutic pathways that enable people to experience more optimal health across the life course.

Sutin, College of Medicine Associate Professor of Geriatrics Antonio Terracciano and others have published research showing that those who show more conscientiousness generally experience better health outcomes and greater longevity. Neuroticism leads in the other direction.

Managing health behaviors associated with conscientiousness and neuroticism, then, could be an effective intervention to address health problems.

In the ongoing study, Sutin hopes to gain understanding about how these traits emerge, potentially leading to new ways of mitigating unwanted behaviors linked to personality.

This project really began with thinking about where personality traits come from, she said. It makes more sense to intervene at the source rather than later in life.

Read more from the original source:
FSU researchers receive $2.8 million grant to search for the origin of personality traits impacting longevity - Florida State News

Are Behavioral Science, Customer Centricity And Customer Experience Compatible? – Forbes


Forbes
Are Behavioral Science, Customer Centricity And Customer Experience Compatible?
Forbes
However, at the same time, many of those companies will also be leveraging a large number of the powerful insights that are coming out of behavioral science, behavioral economics and behavioral design and will be using them to help design and deliver a ...

and more »

Read more:
Are Behavioral Science, Customer Centricity And Customer Experience Compatible? - Forbes

To Counter Opioid Crisis, NIH Pushes Researchers to Invent More Drugs – The Chronicle of Higher Education (subscription)

At a time when opioid abuse is killing tens of thousands of Americans a year, government-funded university scientists are now being asked to pursue a solution many of them find deeply misguided: Invent even more drugs.

More than a dozen invited drug companies are eager to help, the NIHs director, Francis S. Collins, said of his agencys new opioid strategy. "They have all responded with a great deal of enthusiasm," he said.

But academic experts in opioid abuse are aghast, saying the NIH plan appears to greatly overemphasize the prospect of meaningful help from the drug companies which the scientists blame for creating the crisis in the first place to the near exclusion of nonpharmacological treatments, including lifestyle changes and economic development.

"This is a complex bio-psycho-social disease," said one opioid expert, Anna Lembke, an assistant professor of psychiatry and behavioral sciences at Stanford University, "and these interventions really are only looking at the biology piece."

This is a complex bio-psycho-social disease, and these interventions really are only looking at the biology piece.

For such researchers, the issue reflects a fundamental question about the role of the NIH: Should it direct research dollars mostly toward traditional "bench science" or take a more expansive and interdisciplinary approach to major matters of public health?

To some degree, the NIH accepts that wider definition. The NIH division that produced the new opioid strategy, the National Institute on Drug Abuse, has sponsored research into areas that include improving educational initiatives in schools and assessing programs to monitor prescription drugs.

But the NIH plan, published on Wednesday in The New England Journal of Medicine and written by Dr. Collins and Nora D. Volkow, director of the drug-abuse institute, spoke almost exclusively of ideas for developing new drugs and devices to improve upon and replace opioids, to vaccinate against the effect of opioids, and to improve post-overdose treatment.

The strategy is an outgrowth of an annual meeting, held in April, between pharmaceutical-industry leaders and officials at the NIH and other government health agencies. More details of the plan will be developed during three additional meetings over the next six weeks, all closed to the public, between industry scientists and NIH officials, Dr. Collins said.

The stars are aligning now between the science and the industry, seeing this as a potential market opportunity.

Dr. Collins and Dr. Volkow, in a briefing with reporters, also said the epidemic of opioid addiction now affecting at least 2.5 million Americans grew in large part because the dangers were not understood as recently as 20 years ago.

"The medical profession was very much kind of buying into the idea that this could be a way in which one could manage not just short-term but long-term pain," Dr. Collins said. "The realization of the addictive potential was much more limited then than it is now."

We've known for millennia that opioids are addictive and that they cause overdose when taken in too high a dose.

New drugs could be useful, said Richard B. Gunderman, a professor of radiology at Indiana University who holds appointments in several other fields, including medical education and philosophy. But rather than pursue new types of opioids as the holy grail, Dr. Gunderman said, scientists should look at psychological, spiritual, and even cultural factors that lead to opioid abuse, especially among people suffering from low incomes and a lack of fulfilling careers.

Such factors are critical, he said, "and we neglect them at our peril."

Dr. Volkow did mention some nonpharmacological goals, including improving training for emergency-room physicians and doctors in sexual-health clinics who treat opioid-abuse patients.

And the U.S. secretary of health and human services, Thomas E. Price, told a drug-abuse summit in April that improving access to treatment and recovery services was one of his top five priorities in fighting opioid abuse.

At the same time, a House-approved plan for meeting the Trump administrations request to overhaul federal health-care coverage would reduce patients eligibility for Suboxone, the leading long-term treatment for opioid addiction. Losing access to Suboxone "would definitely make the epidemic worse," Dr. Kolodny said.

The NIH plan is so worrisome, Dr. Lembke said, because the drug industry can already provide resources to develop new drugs. Federal money, by contrast, should be directed toward approaches that industry will not cover, such as studying the value of clean-needle-exchange programs, safe-injection facilities, decriminalization policies, and personal behaviors, including exercise, yoga, and tai chi, she said.

"Not a single one of their listed interventions addresses the psychosocial contextual problems that are so central to this" crisis, Dr. Lembke said of the NIH plan.

Paul Basken covers university research and its intersection with government policy. He can be found on Twitter @pbasken, or reached by email at paul.basken@chronicle.com.

See original here:
To Counter Opioid Crisis, NIH Pushes Researchers to Invent More Drugs - The Chronicle of Higher Education (subscription)

Eco-Pass fee increase fight ramps up – La Voz Weekly

Students at De Anza College are ramping up the fight to oppose the proposed increase of the Eco-pass fee from $9 to $40. The VTA board will vote on the issue at their June 1 board meeting.

Over this past week, organizers leading the opposition from De Anza have met with many VTA board members including Chappie Jones and Cindy Chavez.

They have also received endorsements from De Anza College, the Associated Students of San Jose State and Foothill College, Assemblymembers Evan Low and Ash Kalra, Congressman Ro Khanna, and the Amalgamated Bus Union.

Chi Tran, 21, environmental economics and public policy major; Neil McClintick, 20, political science major; Raphael Villagracia, 19, political science major, and Eddie Cisneros, 23, public health major, met board member Jones, who was not very receptive to students concerns, at the West Valley Branch Library for a second meeting.

We brought him our statistics and proposals for a solution, Tran said. He was very impressed with us and we might convince him a bit more than the first time.

Tran; McClintick; Cisneros; Desiree Humphers, 20, liberal arts and behavioral science major; and Patrick Ahrens, advisor to California Assemblymember Evan Low, met with board member Chavez at the Santa Clara County building. Tran said they had a very successful meeting and she was very impressed with Chavez.

She knows her stuff and she will take us very seriously, Tran said. Her goal is to keep public transportation floating, so she is seeking for a sustainable plan.

A few organizations on campus including the ES Committee, TRANSITion and the De Anza Political Revolution are very active on campus in preparation for the upcoming meeting.

TRANSITion is planning to host workshops to create posters, and the De Anza Political Revolution is planning to host workshops to prepare students to give testimonies during the meeting.

April Nicholson, 19, political science major, and member of the DASB Environmental Sustainability Committee and De Anza Political Revolution Club, has been circulating a petition and attending VTA board meetings. She presented the issue and gathered at least 2,180 signatures from 15 classrooms over three days.

Organizers are contacting as many council members as they can as well as receiving support from elected officials, and are trying to get more students involved in the issue.

We really hope students give more attention to this issue, said Tran. Many of us who are organizing this work are leaving the school. It wont affect us, but affect folks that are staying: the future students.

Follow this link:
Eco-Pass fee increase fight ramps up - La Voz Weekly

Scientists Want a Vaccine to Protect Readers From Fake News – Sputnik International

Politics

01:35 01.06.2017(updated 10:42 01.06.2017) Get short URL

As those seeking topromulgate a biased point ofview label so much information "fake news," behavioral scientists are now studying whether the human mind can be induced torecognize and refute it.

In a recent study, 100 participants were provided witha scientific report, butwere also informed that intentional misinformation would be included. Participants inthe behavioral study, followingthe warning, were able toidentify the false facts 100 percent ofthe time, asnoted byRawstory.com.

The study participants were informed that "fake experts" are typically used byindustries seeking torefute scientific consensus, and the end results indicated that politics and values were not indicative ofthe study group's ability toidentify falsehoods.

"Nobody likes tobe misled, no matter their politics," said a researcher involved withthe project, an indicator, they added, that it is possible forpeople toavoid being led astray bylies.

Observing that humans instinctively reject facts that contradict their personal belief systems, Yale University professor Dan Kahan's identification ofwhat he calls identity-protective cognition, results ina person identifying withinformation aslong asit supports their own beliefs.

Now scientists are seeking a way toinoculate againstthe practice, toallow fora person torecognize a provable scientific truth astruth and alter their point ofview.

But what is truth?

Sputnik/ Vladimir Astapkovich

Previous studies byCambridge psychology professor Sander van der Linden have shown that simple acceptance ofthe existence ofanother point ofview can assist inallowing those withdefensively held beliefs toentertain the possibility ofchanging their viewpoint.

Scientists, including van der Linden, agree that acceptance ofanother's viewpoint can smooth overcombative defensive reactions, including amongthose who resist factual information merely because it challenges their belief system.

"Consensus messages don't ask people tochange their beliefs they ask them tochange their opinion aboutwhat other people believe, so they're not a direct threat totheir identity," van der Linden detailed.

Suggesting that, byaccepting that another point ofview can co-exist withyours, it is possible tobring climate change deniers aroundto the provable negative environmental truth, the scientists said, "We've found that they're one way toget people more aligned onthe side ofclimate science."

"You can't talk around [climate change denial]; otherwise it persists," van der Linden said, according toVox.

In offering a scientific truth, he observed, it is helpful tocome right outand say it.

"What's important is tolead withthe facts the facts are the headline then introduce the myth, and then explain why it's wrong."

"There is a consensus ofevidence that human activity is causing all ofrecent global warming. Not some ofit. Not even most ofit. All ofit," he explained.

Noting that it is "all-too-easy tomislead people intothinking that experts disagree onhuman-caused global warming," van der Linden suggested that, "If you want towork outwhether you're getting taken inwith the fake-expert strategy, take a closer look atthe experts' who are being cited."

Cognitive scientist and author ofthe Skeptical Science blog John Cook, an adjunct lecturer atAustralia's University ofQueensland speaking abouthow conflicting views can coexist withina person's belief system offered that people "want toknow how these two things can exist together. So you have toresolve it, and that turns intoa compelling story."

Original post:
Scientists Want a Vaccine to Protect Readers From Fake News - Sputnik International

Antibody Fights Fat, Fires up Metabolism – Anti Aging News

Two international research teams have determined an antibody decreases fat while simultaneously boosting metabolism. Their studies involved mice yet it is believed the findings will also apply to humans. It is hoped that this breakthrough will help treat osteoporosis, obesity and a number of other conditions.

About FSH

It is known that a specific antibody targets follicle-stimulating hormones (FSH). These hormones increase when menopause occurs. Menopause is tied to a number of different health problems in women like the loss of bone density and an increase in weight gain. FSH is generated by the pituitary gland in mammals of both sexes. It spurs the growth of ovarian follicles in females and also regulates several reproductive processes. The antibody in question heightens bone mass, increases metabolism and decreases body fat in mice. It is believed that blocking FSH to counteract menopause symptoms will help treat conditions like cardiovascular disease, obesity, cancer, and osteoporosis.

About the Study

The two international research teams were supervised by Clifford J. Rosen, Li Sun, and Mone Zaidi. The teams performed their work at the Maine Medical Center Research Institute and the Icahn School of Medicine at Mount Sinai. They used a synthetic mouse antibody to key in on a 13-amino-acid sequence of a single subunit of FSH. The antibody was tested on female mice whose ovaries were removed. The removal of the ovaries caused high levels of FSH. The antibody was also tested on female and male mice that were provided with high-fat foods.

The Findings

In both instances, treatment using the antibody spurred fat loss and a faster metabolism. The results have intrigued scientists and medical professionals around the world. More extensive studies will be performed in the near future to determine if the findings are relevant to human health.

Read this article:
Antibody Fights Fat, Fires up Metabolism - Anti Aging News

Here’s Why Editas Medicine Fell as Much as 15.7% Today – Madison.com

What happened

Shares of gene editing pioneer Editas Medicine (NASDAQ: EDIT) dropped nearly 16% today after a new study published in Nature Methods drew attention to unintended effects of using the highly touted genetic engineering tool known as CRISPR. Shares of genome-editing peers CRISPR Therapeutics (NASDAQ: CRSP) and Intellia Therapeutics (NASDAQ: NTLA) were down as much as 6.9% and 14.9%, respectively, on the news.

The study, conducted by a team from Columbia University Medical Center, provided data showing that the technology can "introduce hundreds of unintended mutations into the genome," according to Genetic Engineering & Biotechnology News. That contradicts one of the better-known characteristics of CRISPR: precision.

Simply put, it's not sitting well with investors, who are (in knee-jerk fashion) adjusting the value placed on early-stage platforms, especially Editas Medicine, which will be the first of the group to enter clinical trials. As of 3:31 p.m. EDT, the stock had settled to a 11.3% loss.

Image source: Getty Images.

The study is among the first to quantify the specificity of CRISPR tools, which work by delivering gene editing enzymes to specific parts of the genome through the use of synthetic guide RNAs. Or that's how they're supposed to work. The authors of the study show that although intended edits can be made with respectable efficiency, such as correcting a mutation in a gene that causes blindness in mice, there are also unintended secondary edits made to the genome.

This may seem like a bombshell report, but it's a matter of optics. Researchers have never shied away from the reality that CRISPR gene editing tools can stray off target and make unintended edits to genomes in mammalian cells (i.e., humans). Many labs -- including Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics -- are working on increasing the efficiency and specificity of the technology. This is how science works. By quantifying these off-target mutations, which the paper attempted to do, researchers can begin to better understand how to improve the technology.

Investors and traders did not take the same cool-headed approach to the news, instead giving into a knee-jerk reaction to adjust the value of each pre-clinical technology platform. While off-target edits could prove troublesome for a CRISPR therapeutic used in humans, it's important to remember that there are currently no clinical trials underway in the United States. Editas Medicine will become the first to initiate a clinical trial later this year.

The sharp contrasts in reactions from researchers and investors is likely driven by how CRISPR is perceived by the media. Unfortunately, there is a generous amount of hyped-up science journalism that sticks to simple narratives -- "CRISPR has arrived and will cure all diseases!" -- instead of more nuanced takes that give equal weight to each current obstacles and future potential facing an emerging technology. Just remember: Biology is never quite so simple.

The results from the study don't really change anything, except for bringing more attention to the already existent clinical risk inherent to the development of early-stage CRISPR therapeutics. There is still plenty of work and new technology left to be developed before gene editing fulfills its promise in treating and curing human diseases. Hopefully, this can be a long-term positive for investors in CRISPR stocks by forcing them to listen to the fundamental hurdles for the technology. Hopefully.

10 stocks we like better than Editas Medicine

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Editas Medicine wasn't one of them! That's right -- they think these 10 stocks are even better buys.

*Stock Advisor returns as of May 1, 2017

Maxx Chatsko has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

View original post here:
Here's Why Editas Medicine Fell as Much as 15.7% Today - Madison.com

Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine – Xconomy

Xconomy National

The randomized controlled trial has long been held up as the gold standard for testing new drugs. But the nations top drug evaluator, Janet Woodcock, believes they arent necessary for all new experimental treatments. Randomized trials are long, expensive to run, and ultimately produce limited answers, she said at a medical conference last week.

The ability to use genetic information to classify patients and match them to potential therapies opens up new possibilities for evaluating drugs. As these capabilities increase, Woodcock says, the FDA should adjust its approach to reviewing drugs.

People have been very happy with the use of the traditional standard randomized controlled trial, Woodcock said last Thursday at the Precision Medicine World Conference at Duke University. People know how to interpret that evidence. Yet that may not be appropriate for some of these diseases.

The FDA has shown such flexibility with two recent approvals based on better genetic insights. Last week, the FDA approved Mercks (NYSE: MRK) cancer drug pembrolizumab (Keytruda) for all solid tumors with a specific genetic signature, regardless of where in the body the cancer started. That decision came days after the regulator expanded use of Vertex Pharmaceuticals (NASDAQ: VRTX) cystic fibrosis drug, ivacaftor (Kalydeco), so more patients with a particular genetic mutations could get treatment. The additional approvals for both drugs did not require the companies to conduct more randomized controlled trials. Woodcock described the approvals as landmarks for precision medicine.

Pembrolizumab was already approved to treat cancers of the skin, lung, and bladder, among others. The data supporting the latest approval for the Kenilworth, NJ-based companys drug came from open-label basket trials that simultaneously tested pembrolizumab on a variety of tumors that all share a specific genetic alteration. Patients were selected for the studies based on genetic tests that identified that signature, a predictor of whether they would respond to the Merck therapy. The FDAs ruling was an accelerated approval, meaning Merck must gather additional evidence to confirm the earlier studies. Woodcock said that this type of flexible approach is particularly important for diseases that have no treatment alternatives.

Genetic information has also played a role in the development and approval of Vertexs cystic fibrosis drug, ivacaftor. The drug was initially approved to treat patients who have specific mutations that indicate they would respond to the drug. On May 17, the FDA expanded the approval from 10 mutations to 33. Woodcock said the FDA based this decision on several factors, but the main evidence was a laboratory test that showed the drug could also help CF patients with more gene mutations. Woodcock said that this decision opens a pathway for drugs in cystic fibrosis and other diseases that have similar signs and symptoms. After a drug is first approved, a drugmaker could get additional approvals for additional patient subsets by using the lab test, rather than conducting a randomized clinical trial for each group.

The FDA and drug companies have been talking about adding new approaches to clinical trials for years, and that effort is now getting a nudge forward under federal law. Among the provisions of the wide-ranging 21st Century Cures Act, signed into law last year, are requirements that the FDA hold public hearings and issue guidance to help drug companies use new clinical trial designs to test their drugs. The law also calls on the FDA to use real-world evidence to support applications for new uses of already approved drugs. (Regulatory Affairs has a good breakdown of what the new federal law means for the FDA.)

Woodcock didnt reference the Cures Act in her remarks. But she said that for some drugs, different trial designs are warranted. Platform trials might be useful to evaluate multiple drugs and drug combinations simultaneously, with the ability to adjust the studies on the fly by adding or dropping arms. This flexibility allows Next Page

Frank Vinluan is editor of Xconomy Raleigh-Durham, based in Research Triangle Park. You can reach him at fvinluan [at] xconomy.com

Go here to read the rest:
Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine - Xconomy

A Fresno staffer finds his way from business to high school chemistry teacher – EdSource

Patrick Jensen happily teachers high school chemistry after a 20 year career in business.

Patrick Jensen happily teachers high school chemistry after a 20 year career in business.

Patrick Jensen, 41, took a 50 percent pay cut to teachchemistry and web development in the Fresno Unified School District.

After working for 20 years as a fiscal analyst, mutual fund accountant and school district business chief, he decided a great career isnt always about money.

In my old job, I felt like I was pushing a lot of paperwork around but not making much of a difference. He said. I wanted to do something more directly connected to kids, have more of an impact on my community.

Last year, Jensen quit his job and enrolled in a teacher intern credential program at Fresno State. After taking an intense summer course, he started at Patino High School, a newly-opened, business-themed school in Fresno. Weekends and nights he takes teacher preparation classes, and works closely with colleagues and mentor teachers.

He had never volunteered in a classroom, and his mastery of chemistry dated from his years as an undergraduate. But overall, his first months in the classroom went very smoothly, thanks to colleagues support. He has no regrets.

The toughest part, he said, was getting used to teenagers. Until he started teaching, most of his experience with kids was from raising his own. Understanding teenagers and keeping them engaged was a little more challenging than he expected.

If youre not used to teenagers, its hard to know how much freedom to give them, where to draw the line, when are you being too strict, he said. You can have a great career and be an expert in something, but you might not know how to teach. You have to have the humility and openness to ask for help.

He encourages other mid-career professionals in science and math to consider teaching if theyre looking for a change, have the support of their families and dont mind a few years of sacrifice in exchange for long-term job stability, summers off and the rewards of educating young people.

When youre teaching, you see these moments of growth with the kids, when they suddenly grasp a concept they previously didnt understand . Those moments make it all worth it, he said. And if it turns out you dont like teaching, you can always go back to that boring office job. Those jobs will always be there.

More here:
A Fresno staffer finds his way from business to high school chemistry teacher - EdSource

Everything from pirate games to bioengineering – Shanghai Daily (subscription)

I applied for the trip because I thought it sounded enjoyable and exciting and I would be able to learn about new things. I most enjoyed Pirate Training, where we got to make cannons, take part in fencing and archery and play capture the flag in an ice rink.

These are things I never thought I would do. Meeting the other students from NAE was great because they all seemed very similar to me and that made me feel a lot more confident about myself. It was also good fun to make new friends from around the world who I can continue to connect with through Nord Anglias Global Classroom.

MIT was a huge university, if I went there Id worry about getting lost but it looked like a nice place to live and learn. The same can be said for Harvard, which we also really enjoyed spending time at and learning about. If youre lucky enough to be picked next year, be prepared to take part in a range of activities which will make you work hard both physically and mentally, and pack some comfortable shoes as the MIT and Harvard sites are big and we did a lot of walking in order to visit the different facilities!

Iwan Jones, Year 7 student

When I first saw the STEAM (science, technology, engineering, art and maths) festival being offered by BISS Puxi I thought it would be an awesome opportunity to see how MIT use their research to apply science to the real world, and I was excited about these subjects. I knew it would be a great chance to work with other students who shared similar interests and to speak to students studying at MIT.

The activity I enjoyed the most was Biobuilder. In this session we learnt about how, in the future, we will be able to take parts of cells, which perform a certain function, and build it to make a new cell.

The most interesting aspect is these cells can be designed so they can be controlled to complete certain tasks. We used different shapes and colors to represent these different functions, and built a cell that would kill only cancer cells. This is a lot harder in real life, as you would need to take the cell and find what the function is before fusing the different parts together.

It was really fun working with schools from around the world, and we all felt like one big school. It was very easy to make friends with everyone and we were very upset to leave each other on Friday.

This experience has inspired me to go to a school like MIT because of all the different fields in science and technology I can have the chance to experience if I studied there. Some advice Id give to a student who plans to go next year is to really throw yourself into every activity and to make the most of this experience.

Alison Ohene-Djan, Year 7 student

When I heard about the chance to go to MIT I was really excited and applied to attend as I was sure I would learn a lot and I might not get the chance to attend something like this again.

Once we arrived we met with the students from all of the other Nord Anglia schools; I enjoyed working with different people from different places because they all had other stories and ideas to share. The fun really started once we got to start on the STEAM activities, I cant single out one particular activity because each one was a unique experience and fun in their own way, although I did enjoy being a pirate. This trip has inspired me to continue to work on areas of STEAM, Ive had the interest of going to universities like MIT before, but this trip just made me even more motivated to work hard and be accepted into a place like MIT. The one piece of advice I would give to students who plan to attend next years trip is to not worry so much about remembering everything that will be taught to you, if you enjoy and focus on the activity, you will pick it up along the way.

Liam Chan, Year 7 student

I applied for the trip because it is a once in a lifetime experience at one of the best universities in the world. Also, we would meet students from Nord Anglia schools around the world.

My favorite part was the 2.009 workshop, where in groups of ten we designed, and actually created, carnival games which could be used in real carnivals. Working with Professor David Wallace was a real highlight. I enjoyed collaborating with other schools because people from all across the globe worked together and came up with so many ideas to try and give the best possible answer.

The trip has definitely inspired me to attend MIT or universities like MIT because they have really good facilities and the professors teach lessons in a very exciting and interesting way. Advice that I would give students going next year would be: when stuck on a problem, look at things from a different perspective. The answer is usually there, it just needs more thought to reach it.

Emma Tang, Year 7 student

Go here to see the original:
Everything from pirate games to bioengineering - Shanghai Daily (subscription)

Are These Two Of The New Characters In ‘Grey’s Anatomy’ Firefighter Spinoff? – moviepilot.com

A few weeks ago, Grey's Anatomy fans were overjoyed to hear that Shonda Rhimes is expanding the Grey's universe with a spinoff series focusing on the personal and professional lives of Seattle's firefighters.

The yet-to-be-titled series is the second spinoff from Grey's Anatomy Private Practice ran from 2007 until 2013 and will be executive produced by both Rhimes and Betsy Beers. Long time #GreysAnatomy writer and producer, Stacy McKee, will act as showrunner.

But while we've been given details about the crew of what will no doubt become a popular series, the information about the characters of the series has been less forthcoming. However, one hint we have been given came during the Grey's Anatomy Season 13 finale, when the hospital required evacuation during the explosion.

As fans will remember, part of the hospital exploded after Stephanie's plan to set the rapist on fire went awry. With the hospital quickly burning, firefighters were soon on the scene to battle the flames and help rescue patients and doctors. Given the news about the firefighter spinoff series was announced shortly before the finale aired, it was implied that some of the firefighters from the Season 13 finale will appear in new series. So who did we see in Episode 13 that might crop again? Take a look:

We were first introduced to firefighter Carroll while announcements were being made on how the hospital buildings will be evacuated. Carroll later accompanied Ben inside to find Stephanie, and we learned she was actually the fire captain when she was called on to inspect the body of the rapist killed in the blast.

Given that Shonda Rhimes' series are so often led by strong female characters, it would be no surprise to see actor Stephanie Czajkowski return as firefighter Carroll in the new spinoff in a major role. When asked about the possibility of her character return, Czajkowski was unable to give a definite answer, though remarked that it would "be a dream come true to have Firefighter Carroll be a part of the expansion of Shondaland."

We briefly met firefighter Ben as he came across Meredith, Riggs and nurse Bohkee while Riggs was part way through a lobectomy. After first ordering the group to evacuate, he eventually gave them 15 minutes to close up the patient, and assured Meredith that the firefighters were all keeping an eye out for the missing Erin.

The actor who played firefighter Ben is Nelson Grande, a man who is no stranger to hospital dramas having already starred in General Hospital, but what's even more interesting is that Grande apparently studied Fire Science in college before dropping out to pursue his acting dream. Talk about a perfect role!

Visit link:
Are These Two Of The New Characters In 'Grey's Anatomy' Firefighter Spinoff? - moviepilot.com

Antibody Fights Fat, Fires up Metabolism – Anti Aging News

Two international research teams have determined an antibody decreases fat while simultaneously boosting metabolism. Their studies involved mice yet it is believed the findings will also apply to humans. It is hoped that this breakthrough will help treat osteoporosis, obesity and a number of other conditions.

About FSH

It is known that a specific antibody targets follicle-stimulating hormones (FSH). These hormones increase when menopause occurs. Menopause is tied to a number of different health problems in women like the loss of bone density and an increase in weight gain. FSH is generated by the pituitary gland in mammals of both sexes. It spurs the growth of ovarian follicles in females and also regulates several reproductive processes. The antibody in question heightens bone mass, increases metabolism and decreases body fat in mice. It is believed that blocking FSH to counteract menopause symptoms will help treat conditions like cardiovascular disease, obesity, cancer, and osteoporosis.

About the Study

The two international research teams were supervised by Clifford J. Rosen, Li Sun, and Mone Zaidi. The teams performed their work at the Maine Medical Center Research Institute and the Icahn School of Medicine at Mount Sinai. They used a synthetic mouse antibody to key in on a 13-amino-acid sequence of a single subunit of FSH. The antibody was tested on female mice whose ovaries were removed. The removal of the ovaries caused high levels of FSH. The antibody was also tested on female and male mice that were provided with high-fat foods.

The Findings

In both instances, treatment using the antibody spurred fat loss and a faster metabolism. The results have intrigued scientists and medical professionals around the world. More extensive studies will be performed in the near future to determine if the findings are relevant to human health.

Read the original:
Antibody Fights Fat, Fires up Metabolism - Anti Aging News

Behavioral neuroscience – Wikipedia

Behavioral neuroscience, also known as biological psychology,[1]biopsychology, or psychobiology[2] is the application of the principles of biology to the study of physiological, genetic, and developmental mechanisms of behavior in humans and other animals. [3]

Behavioral neuroscience as a scientific discipline emerged from a variety of scientific and philosophical traditions in the 18th and 19th centuries. In philosophy, people like Ren Descartes proposed physical models to explain animal and human behavior. Descartes, for example, suggested that the pineal gland, a midline unpaired structure in the brain of many organisms, was the point of contact between mind and body. Descartes also elaborated on a theory in which the pneumatics of bodily fluids could explain reflexes and other motor behavior. This theory was inspired by moving statues in a garden in Paris.[4]

Other philosophers also helped give birth to psychology. One of the earliest textbooks in the new field, The Principles of Psychology by William James, argues that the scientific study of psychology should be grounded in an understanding of biology:

Bodily experiences, therefore, and more particularly brain-experiences, must take a place amongst those conditions of the mental life of which Psychology need take account. The spiritualist and the associationist must both be 'cerebralists,' to the extent at least of admitting that certain peculiarities in the way of working of their own favorite principles are explicable only by the fact that the brain laws are a codeterminant of their result.

Our first conclusion, then, is that a certain amount of brain-physiology must be presupposed or included in Psychology.[5]

The emergence of both psychology and behavioral neuroscience as legitimate sciences can be traced from the emergence of physiology from anatomy, particularly neuroanatomy. Physiologists conducted experiments on living organisms, a practice that was distrusted by the dominant anatomists of the 18th and 19th centuries.[6] The influential work of Claude Bernard, Charles Bell, and William Harvey helped to convince the scientific community that reliable data could be obtained from living subjects.

Even before the 18th and 19th century, behavioral neuroscience was beginning to take form as far back as 1700 B.C.[7] The question that seems to continually arise is what is the connection between the mind and body. The debate is formally referred to as the mind-body problem. There are two major schools of thought that attempt to resolve the mindbody problem; monism and dualism.[4]Plato and Aristotle are two of several philosophers who participated in this debate. Plato believed that the brain was where all mental thought and processes happened.[7] In contrast, Aristotle believed that the brain served the purpose of cooling down the emotions derived from the heart.[4] The mind-body problem was a stepping stone toward attempting to understand the connection between the mind and body.

Another debate arose about was localization of function or functional specialization versus equipotentiality which played a significant role in the development in behavioral neuroscience. As a result of localization of function research, many famous people found within psychology have come to various different conclusions. Wilder Penfield was able to develop a map of the cerebral cortex through studying epileptic patients along with Rassmussen.[4] Research on localization of function has led behavioral neuroscientist to a better understanding of which parts of the brain control behavior. This is best exemplified through the case study of Phineas Gage.

The term "psychobiology" has been used in a variety of contexts, emphasizing the importance of biology, which is the discipline that studies organic, neural and cellular modifications in behavior, plasticity in neuroscience, and biological diseases in all aspects, in addition, biology focuses and analyzes behavior and all the subjects it is concerned about, from a scientific point of view. In this context, psychology helps as a complementary, but important discipline in the neurobiological sciences. The role of psychology in this questions is that of a social tool that backs up the main or strongest biological science. The term "psychobiology" was first used in its modern sense by Knight Dunlap in his book An Outline of Psychobiology (1914).[8] Dunlap also was the founder and editor-in-chief of the journal Psychobiology. In the announcement of that journal, Dunlap writes that the journal will publish research "...bearing on the interconnection of mental and physiological functions", which describes the field of behavioral neuroscience even in its modern sense.[8]

In many cases, humans may serve as experimental subjects in behavioral neuroscience experiments; however, a great deal of the experimental literature in behavioral neuroscience comes from the study of non-human species, most frequently rats, mice, and monkeys. As a result, a critical assumption in behavioral neuroscience is that organisms share biological and behavioral similarities, enough to permit extrapolations across species. This allies behavioral neuroscience closely with comparative psychology, evolutionary psychology, evolutionary biology, and neurobiology. Behavioral neuroscience also has paradigmatic and methodological similarities to neuropsychology, which relies heavily on the study of the behavior of humans with nervous system dysfunction (i.e., a non-experimentally based biological manipulation).

Synonyms for behavioral neuroscience include biopsychology, biological psychology, and psychobiology.[9]Physiological psychology is a subfield of behavioral neuroscience, with an appropriately narrower definition

The distinguishing characteristic of a behavioral neuroscience experiment is that either the independent variable of the experiment is biological, or some dependent variable is biological. In other words, the nervous system of the organism under study is permanently or temporarily altered, or some aspect of the nervous system is measured (usually to be related to a behavioral variable).

Different manipulations have advantages and limitations. Neural tissue destroyed as a primary consequence of a surgery, electric shock or neurotoxin can confound the results so that the physical trauma masks changes in the fundamental neurophysiological processes of interest. For example, when using an electrolytic probe to create a purposeful lesion in a distinct region of the rat brain, surrounding tissue can be affected: so, a change in behavior exhibited by the experimental group post-surgery is to some degree a result of damage to surrounding neural tissue, rather than by a lesion of a distinct brain region. [23][24] Most genetic manipulation techniques are also considered permanent.[24] Temporary lesions can be achieved with advanced in genetic manipulations, for example, certain genes can now be switched on and off with diet.[24] Pharmacological manipulations also allow blocking of certain neurotransmitters temporarily as the function returns to its previous state after the drug has been metabolized.[24]

In general, behavioral neuroscientists study similar themes and issues as academic psychologists, though limited by the need to use nonhuman animals. As a result, the bulk of literature in behavioral neuroscience deals with mental processes and behaviors that are shared across different animal models such as:

However, with increasing technical sophistication and with the development of more precise noninvas
ive methods that can be applied to human subjects, behavioral neuroscientists are beginning to contribute to other classical topic areas of psychology, philosophy, and linguistics, such as:

Behavioral neuroscience has also had a strong history of contributing to the understanding of medical disorders, including those that fall under the purview of clinical psychology and biological psychopathology (also known as abnormal psychology). Although animal models do not exist for all mental illnesses, the field has contributed important therapeutic data on a variety of conditions, including:

Nobel Laureates

The following Nobel Prize winners could reasonably be considered behavioral neuroscientists or neurobiologists. (This list omits winners who were almost exclusively neuroanatomists or neurophysiologists; i.e., those that did not measure behavioral or neurobiological variables.)

Kavli Prize in Neuroscience

Read the rest here:
Behavioral neuroscience - Wikipedia

Wright State spinoff closes on $680K in funding – Dayton Business Journal

Wright State spinoff closes on $680K in funding
Dayton Business Journal
The company has closed on a $680,000 Seed B convertible note, which brings the total amount of seed funding it has raised to $845,000. This comes on top of the $2 million in grants it landed as part of the Kno.e.sis center at Wright State, thanks to ...

Read more here:
Wright State spinoff closes on $680K in funding - Dayton Business Journal

Surgery Is No Longer Your Only Option! – The Clermont News Leader

Now That We Have Your Attention Did you know Orlando Spine and Joint offers regenerative therapy? When you hear of regenerative medicine, you may be thinking things such as anti-aging, hair restoration, and wrinkle reduction. While these things are technically classified as regenerative medicine, they are not at all that we do. In an effort to help your body heal itself, and regenerate lost or broken tissues, we employ 2 major techniques. One is PRP, which stands for Platelet Rich Plasma. By drawing some blood from your arm, then spinning it in a special centrifuge, we are able to gather just the platelets and some of the plasma. This is then used as an injection into the injured area of your body, acting like a boost or jump start to your natural healing ability. We also use stem cell type therapy. By partnering with the University of Miamis tissue bank, along with New Life Regenerative Medicine, we can offer the latest, most technically sound, and purest form of stem cell type therapy available to you today, called AlloGen. 100% natural, AlloGen contains components that enhance your bodys ability to heal and regenerate itself. Instead of simply managing pain, AlloGen may contribute to minimizing or eliminating pain all together. Both PRP and AlloGen are ideal choices for patients considering regenerative medicine therapy for conditions such as: sports injury, joint pain, arthritis, soft tissue tears, plantars faciitis, carpal tunnel, neck and back pain and many more. Call today for a free consultation with the doctor. 407-614-5900. Orlando Spine & Joint, 821 Oakley Seaver Drive, Clermont, FL 34711. http://www.OrlandoSpineAndJoint.com

View original post here:
Surgery Is No Longer Your Only Option! - The Clermont News Leader